Literature DB >> 12832218

Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.

Xiaohong Wang1, Zhaohui Wang, Neil D Christensen, Joakim Dillner.   

Abstract

Most human antibodies against HPV16 can be blocked by the monoclonal antibody H16.V5. To investigate whether H16.V5 and human sera recognize similar epitopes, hybrid capsids containing different parts of HPV16 and HPV11 were evaluated for reactivity with human sera. The antibody responses among HPV 16-/HPV11+sera to HPV11 and to hybrid capsids containing the HPV11 C-terminus were strongly correlated. The antibody responses among HPV 16+/HPV11-sera to HPV16 and to a hybrid containing the HPV16 C-terminus were correlated and there was also reactivity with a hybrid containing the H16.V5 epitope in the HPV11 backbone. Several HPV16-/11- children's sera were reactive with hybrid capsids, implying that a native capsid structure is essential for serological specificity. For both HPV16 and HPV11, the major serologic reactivity was directed toward the C-terminal part of the protein and the H16.V5 binding site appeared to be a major serologically reactive epitope of HPV16.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832218     DOI: 10.1016/s0042-6822(03)00179-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Authors:  Hyunwook Lee; Sarah A Brendle; Stephanie M Bywaters; Jian Guan; Robert E Ashley; Joshua D Yoder; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.

Authors:  Joseph J Carter; Greg C Wipf; Margaret M Madeleine; Stephen M Schwartz; Laura A Koutsky; Denise A Galloway
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.

Authors:  Johnnie J Orozco; Joseph J Carter; Laura A Koutsky; Denise A Galloway
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

5.  The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane.

Authors:  Patricia M Day; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

6.  Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.

Authors:  Patricia M Day; Cynthia D Thompson; Christopher B Buck; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

7.  Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.

Authors:  Qinjian Zhao; Yorgo Modis; Katrina High; Victoria Towne; Yuan Meng; Yang Wang; Jaime Alexandroff; Martha Brown; Bridget Carragher; Clinton S Potter; Dicky Abraham; Dave Wohlpart; Mike Kosinski; Mike W Washabaugh; Robert D Sitrin
Journal:  Virol J       Date:  2012-02-22       Impact factor: 4.099

8.  Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.

Authors:  Amina I Ahmed; Sara L Bissett; Simon Beddows
Journal:  Infect Genet Evol       Date:  2013-05-27       Impact factor: 3.342

9.  Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm.

Authors:  Doddy Irawan Setyo Utomo; Sabar Pambudi; Enoch Y Park
Journal:  AMB Express       Date:  2022-01-31       Impact factor: 3.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.